CRISPR Therapeutics AG (CRSP) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of CRISPR Therapeutics AG and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
CRSP
CRISPR Therapeutics AG
$55.43HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
SRRK
Scholar Rock Holding Corporation
$46.81HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — CRSP vs SRRK
growth of $100 · dividends reinvested · last 8yCRSP -13.0% (-1.7%/yr)SRRK +197.8% (+14.6%/yr)SRRK compounded faster over this window
CRSP SRRK
CRSP vs SRRK: by the numbers
- •SRRK is the larger company ($5.61B vs $5.35B market cap).
- •Both run net losses; SRRK's is the smaller (0.00% vs -3368.72% net margin).
Metrics side by side
Valuation
| Metric | CRSP | SRRK |
|---|---|---|
| P/S ratio | 399.21 | N/A |
| P/B ratio | 3.06 | 22.10 |
Profitability
| Metric | CRSP | SRRK |
|---|---|---|
| Gross margin | -6537.01% | 0.00% |
| Operating margin | -16191.40% | 0.00% |
| Net margin | -3368.72% | 0.00% |
| ROE | -25.83% | -161.00% |
| ROIC | -21.12% | -90.04% |
Growth (annualized)
| Metric | CRSP | SRRK |
|---|---|---|
| Revenue CAGR (5Y) | 37.32% | N/A |
| Total return CAGR (5Y) | -13.01% | 7.60% |
Frequently asked
- How have CRSP and SRRK total returns compared?
- Over the past 5 years, CRSP delivered -13.01% and SRRK delivered 7.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CRISPR Therapeutics AG ROEScholar Rock ROECRISPR Therapeutics AG operating marginScholar Rock operating marginCRISPR Therapeutics AG revenue growthScholar Rock revenue growthCRISPR Therapeutics AG free cash flowScholar Rock free cash flow
CRISPR Therapeutics AG & Scholar Rock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.